ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
KraneShares China Alpha Index ETF
33.22
0.0000
成交量:
49
成交額:
1,623.47
市值:
332.22萬
市盈率:
- -
高:
33.22
開:
33.22
低:
33.22
收:
33.22
52周最高:
40.84
52周最低:
30.00
股本:
10.00萬
流通股本:
10.00萬
量比:
0.86
換手率:
0.05%
股息:
10.72
股息率:
32.26%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
港股異動 | 煤炭股午後漲幅擴大 安監從民營礦拓展至國企 或使供給約束更具持續性
中金财经
·
09/08
港股異動 | 丹諾醫藥-B(06872)升逾7% 日前獲納入港股通名單 利福喹酮IIa期概念驗證數據積極
智通财经
·
09/08
港股異動 | 中國海外宏洋集團(00081)升逾5% 前8個月累計合約銷售額按年上升17.5%
智通财经
·
09/08
港股煤炭股午後漲幅擴大,截至發稿,力量發展漲4.37%,報2.03港元;中煤能源漲2.90%,報11.37港元;兗礦能源
智通财经
·
09/08
港股異動 | 博彩股集體回暖 澳門賭收按年連跌三月 機構看好9月按年增長6%
智通财经
·
09/08
港股海光芯正升逾10%
每日经济新闻
·
09/08
港股異動 | 華曦達(00901)升逾5% 公司納入恒生綜合指數成份股及入通落地 邊緣AI概念落地迎關鍵臨界點
智通财经
·
09/08
市場消息:摩爾線程秘密遞交港股上市申請。
智通财经
·
09/08
智譜港股跌超11%
智通财经
·
09/08
港股異動 | 百奧賽圖-B(02315)午後升逾10% 與齊魯製藥簽署全人納米抗體分子非排他授權合作協議
智通财经
·
09/08
南下資金淨買入港股超50億港元。
格隆汇
·
09/08
港股異動 | CRO概念股震盪走高 企業在手訂單呈「量價齊升」 AI製藥有望重塑醫藥研發業態
智通财经
·
09/08
港股異動 | 基石藥業-B(02616)午後升逾6% 獲納入港股通標的證券名單 國際大行相繼看好公司發展前景
智通财经
·
09/08
港股生物醫藥股午後走強,劑泰科技-P漲近15%,百奧賽圖-B、金斯瑞生物科技漲近10%
老虎资讯综合
·
09/08
港股生物技術板塊午後拉升
南方财经网
·
09/08
港股生物技術板塊午後拉升,劑泰科技漲近13%,百奧賽圖升逾8%,雲頂新耀、基石藥業升逾4%。
智通财经
·
09/08
港股午評:恒科指跌1.1%,科網股、金融股拖累大市,銅石油煤炭逆勢走強
中金财经
·
09/08
兩大板塊,多股漲停!芯片龍頭港股上市首日破發
同花顺
·
09/08
港股午評:恒生指數跌0.266%,恒生科技指數跌1.102%
智通财经
·
09/08
港股異動 | 雲頂新耀(01952)早盤升逾5% 星必妥PSVT適應症新藥上市申請在華獲批
智通财经
·
09/08
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/KCAI/news?page=15"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KCAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KCAI\",,,,,undefined,":{"symbol":"KCAI","market":"US","secType":"STK","nameCN":"KraneShares China Alpha Index ETF","latestPrice":33.22,"timestamp":1789395868513,"preClose":33.22,"halted":0,"volume":49,"delay":0,"changeRate":0,"floatShares":100005,"shares":100005,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"09-14 11:00:53 EDT","open":33.22,"high":33.22,"low":33.22,"amount":1623.4655500000001,"amplitude":0,"askPrice":33.91,"askSize":100,"bidPrice":33.06,"bidSize":500,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789416000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":33.22,"sharesOutstanding":250002,"nav":33.38,"aum":3338370.52,"dividendRate":0.322571,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.3209,"preClose":33.22,"latestTime":"16:10 EDT","volume":6,"amount":199.32,"timestamp":1789157404658,"change":0.1009,"changeRate":0.003037,"amplitude":0},"volumeRatio":0.858545},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KCAI\",,,,,undefined,":{"symbol":"KCAI","floatShares":100005,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.858545,"shares":100005,"dividePrice":10.7158,"high":33.22,"amplitude":0,"preClose":33.22,"low":33.22,"week52Low":30,"pbRate":"--","week52High":40.84,"institutionHeld":0,"latestPrice":33.22,"committee":0.666667,"eps":0,"divideRate":0.322571,"volume":49,"delay":0,"ttmEps":0,"open":33.22,"prevYearClose":30.48,"prevWeekClose":33.22,"prevMonthClose":33.259,"prevQuarterClose":32.15,"fiveDayClose":33.21,"twentyDayClose":32.485,"sixtyDayClose":32.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KCAI\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"KCAI","amount":0.080552,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"KraneShares China Alpha Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2025-12-31"},{"date":"2025-12-22","symbol":"KCAI","amount":10.716664,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares China Alpha Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KCAI","amount":0.59272,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares China Alpha Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KCAI\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-18","value":0.59272,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-23","value":10.716664,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2025-12-31","value":0.080552,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KCAI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KCAI\",pageSize:20,pageCount:15,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665288643","title":"港股異動 | 煤炭股午後漲幅擴大 安監從民營礦拓展至國企 或使供給約束更具持續性","url":"https://stock-news.laohu8.com/highlight/detail?id=2665288643","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665288643?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 15:07","pubTimestamp":1788851221,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,煤炭股午后涨幅扩大,截至发稿,力量发展涨4.37%,报2.03港元;中煤能源涨2.90%,报11.37港元;兖矿能源涨2.24%,报13.25港元;中国神华涨1.88%,报45.5港元。华泰证券认为,84号文的出台意味着5·22以来强化的一系列安监措施有望由阶段性整治逐步转向常态化约束,考虑到国有煤企是国内煤炭稳产保供的重要主体,中期供给弹性或进一步下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260908/32363267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4588","161032","VXUS","BK4585","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340203","title":"港股異動 | 丹諾醫藥-B(06872)升逾7% 日前獲納入港股通名單 利福喹酮IIa期概念驗證數據積極","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340203","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665340203?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 15:04","pubTimestamp":1788851053,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,丹诺医药-B涨超7%,该股昨日曾冲高涨超15%,随后跳水收跌逾8%。截至发稿,涨7.45%,报165.8港元,成交额2741.28万港元。消息面上,9月7日起,丹诺医药正式获纳入港股通名单。公司表示,此次获纳入港股通,是资本市场对本公司投资价值、市值规模及流动性的全面认可。丹诺医药专注于细菌感染及细菌代谢相关疾病领域。9月7日,丹诺医药公布,利福喹酮治疗人工关节感染的IIa期概念验证临床取得积极结果,多中心IIb期试验已启动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["FLHK","KCAI","BK1161","VXUS","06872","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340749","title":"港股異動 | 中國海外宏洋集團(00081)升逾5% 前8個月累計合約銷售額按年上升17.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340749","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665340749?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 15:01","pubTimestamp":1788850899,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中国海外宏洋集团涨超5%,截至发稿,涨4.65%,报2.925港元,成交额1567.95万港元。消息面上,中国海外宏洋集团发布公告,在2026年8月份,中海宏洋系列公司实现合约销售额人民币23.48亿元及合约销售面积19.91万平方米,分别按年上升10.1%及下跌2.0%。在2026年1至8月份,累计合约销售额人民币244.21亿元及合约销售面积209.41万平方米,分别按年上升17.5%及12.3%。截至2026年8月底,累计认购未签约额人民币5.75亿元及认购未签约面积4.44万平方米。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493263.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","KCAI","LU1166156734.SGD","BK1555","BK4585","00081","VXUS","LU0702159699.USD","LU0702159343.USD","BK1240"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340645","title":"港股煤炭股午後漲幅擴大,截至發稿,力量發展漲4.37%,報2.03港元;中煤能源漲2.90%,報11.37港元;兗礦能源","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340645","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665340645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 14:56","pubTimestamp":1788850578,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KCAI","BK4585","EWH","VXUS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340646","title":"港股異動 | 博彩股集體回暖 澳門賭收按年連跌三月 機構看好9月按年增長6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340646","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665340646?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 14:54","pubTimestamp":1788850467,"startTime":"0","endTime":"0","summary":"消息面上,澳门博彩监察协调局近日公布,8月赌收218.9亿澳门元,按年跌1.2%,连跌第三个月,按月则续回升8.1%。首8个月计,澳门博彩收入按年升3.7%至1690.5亿澳门元。海通国际发表研究报告指,澳门8月赌收按年下降1.2%,略低于市场预期。该行指出,暑期旺季延续带动市场回暖,海通国际预计9月行业赌收将按年增长6%,恢复至2019年的87.8%,主要受去年同期台风扰动,娱乐场关闭33小时带来的低基数影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493260.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0326950275.SGD","BK1589","BK1610","LU0588546209.SGD","LU1224709979.USD","LU0348784397.USD","LU1048596156.SGD","LU0488056044.USD","LU0417516571.SGD","02282","LU0211977185.USD","LU0821914370.USD","LU1282649067.USD","LU0348783233.USD","LU0593848301.USD","LU1282649810.SGD","BK4585","VXUS","LU0140636845.USD","LU2039709279.SGD","LU1328615791.USD","LU0384037296.USD","BK1172","LU0594300419.USD","LU1166156734.SGD","HK0000288784.HKD","LU0607220059.USD","LU0702159699.USD","KCAI","LU0173614495.USD","LU1880383366.USD","LU0650527681.SGD","00200","LU0737861699.HKD","00880","BK4588","LU0307460666.USD","BK1521","LU0287142896.SGD","00027","HK0000288743.USD","LU0149534421.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665905340","title":"港股海光芯正升逾10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665905340","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665905340?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 14:50","pubTimestamp":1788850239,"startTime":"0","endTime":"0","summary":"港股海光芯正涨超10%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609083867998561.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609083867998561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["KCAI","BK1537","01191","BK4585","BK4588","VXUS","BK1170","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340693","title":"港股異動 | 華曦達(00901)升逾5% 公司納入恒生綜合指數成份股及入通落地 邊緣AI概念落地迎關鍵臨界點","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340693","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665340693?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 14:43","pubTimestamp":1788849824,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,华曦达涨超5%,截至发稿,涨5.11%,报72港元,成交额1518.48万港元。消息面上,近日,华曦达获恒生指数有限公司选定,将纳入恒生综合指数成份股,自2026年9月7日起生效,标志着公司资本市场建设迈出关键一步。与此同时,自9月7日起公司获调入沪港通下港股通标的。华曦达此前披露2026年中期业绩公告,上半年公司实现收入人民币20.95亿元,同比增长36.3%;期内溢利人民币1.81亿元,同比增长75.9%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1156","CHAT","QTOC","VTHR","AIPO","BK1193","KCAI","AGIX","BK4585","00901","VXUS","HSCI","ARTY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665834714","title":"市場消息:摩爾線程秘密遞交港股上市申請。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665834714","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665834714?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 14:20","pubTimestamp":1788848410,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS","KCAI","VXUS","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665334763","title":"智譜港股跌超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665334763","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665334763?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 14:12","pubTimestamp":1788847972,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4585","KCAI","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665934210","title":"港股異動 | 百奧賽圖-B(02315)午後升逾10% 與齊魯製藥簽署全人納米抗體分子非排他授權合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2665934210","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665934210?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:53","pubTimestamp":1788846789,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,百奥赛图-B午后涨超10%,截至发稿,涨8.71%,报63港元,成交额1.29亿港元。消息面上,据百奥赛图官微消息,公司宣布近期与齐鲁制药签署全人纳米抗体分子非排他授权合作协议。本次合作涉及的纳米抗体分子由百奥赛图自主研发的RenNano纳米抗体平台产生。通过此次授权,齐鲁制药可结合其自身研发策略,对相关纳米抗体分子开展进一步研究和开发,后续项目的开发形式将根据项目特点和治疗需求灵活推进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","VXUS","KCAI","BK0216","BK4588","BK4585","BK1191","688796","02315","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665342930","title":"南下資金淨買入港股超50億港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342930","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342930?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:46","pubTimestamp":1788846400,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["KCAI","VXUS","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665996342","title":"港股異動 | CRO概念股震盪走高 企業在手訂單呈「量價齊升」 AI製藥有望重塑醫藥研發業態","url":"https://stock-news.laohu8.com/highlight/detail?id=2665996342","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665996342?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:43","pubTimestamp":1788846222,"startTime":"0","endTime":"0","summary":"分析指出,AI辅助新药研发已不止于概念,而真正可以支撑原创药物从发现走向临床,直至上市。招商证券研报指出,CXO板块景气度明确上行。今年上半年国内CXO板块营收、归母净利润同比分别增长24.5%、52.7%,利润增速接近上一轮周期高点;在手订单与新签订单全面回暖,龙头上调全年指引。此外,AI制药有望重塑医药研发业态,提升药物研发效率,板块亦将受益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493227.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGIX","BK1574","BK4588","HK0000320264.USD","HK0000306685.HKD","06821","HK0000320223.HKD","ARTY","JHMH","HK0000306701.USD","CHAT","BK4585","BK1191","BME","03759","AIPO","BK1583","BK1141","KCAI","03347","01548","BK1576","VTHR","QTOC","01477","VXUS","LRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665426603","title":"港股異動 | 基石藥業-B(02616)午後升逾6% 獲納入港股通標的證券名單 國際大行相繼看好公司發展前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2665426603","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665426603?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:41","pubTimestamp":1788846117,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,基石药业-B午后涨超6%,截至发稿,涨5.27%,报6.385港元,成交额8209.73万港元。消息面上,基石药业-B发布公告,本公司发行并于香港联合交易所有限公司上市的股份获纳入港股通标的证券名单,自2026年9月7日起生效。其中,高盛预计,未来6至12个月将是基石药业关键催化剂密集兑现的阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1161","02616","BK4588","FLHK","VXUS","BK1574","161027","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113703587","title":"港股生物醫藥股午後走強,劑泰科技-P漲近15%,百奧賽圖-B、金斯瑞生物科技漲近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113703587","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113703587?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:33","pubTimestamp":1788845625,"startTime":"0","endTime":"0","summary":"9月8日,港股$生物(000504)$医药股午后走强,$剂泰科技-P(07666)$涨近15%,$百奥赛图-B(02315)$、$金斯瑞生物科技(01548)$涨近10%,$泰格医药(03347)$、$康希诺生物(06185)$、$云顶新耀(01952)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","02315","BK4581","688796","BK4588","BK4585","01548","399441","HK0000320264.USD","BK1161","BK1574","HK0000320223.HKD","09939","01952","BK1141","03347","BK1583","06185","BK1191","BK1576","VXUS","HK0000306685.HKD","XBI","07666","KCAI","HK0000306701.USD","BK1515","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665426123","title":"港股生物技術板塊午後拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=2665426123","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665426123?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:31","pubTimestamp":1788845460,"startTime":"0","endTime":"0","summary":"南方财经9月8日电,港股生物技术板块午后拉升,剂泰科技涨近13%,百奥赛图涨超8%,云顶新耀、基石药业涨超4%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609083867927161.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609083867927161.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","HELX","WDNA","VXUS","BK4588","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665428723","title":"港股生物技術板塊午後拉升,劑泰科技漲近13%,百奧賽圖升逾8%,雲頂新耀、基石藥業升逾4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665428723","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665428723?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:28","pubTimestamp":1788845318,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","KCAI","VXUS","HELX","BK4588","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665344641","title":"港股午評:恒科指跌1.1%,科網股、金融股拖累大市,銅石油煤炭逆勢走強","url":"https://stock-news.laohu8.com/highlight/detail?id=2665344641","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665344641?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 12:27","pubTimestamp":1788841622,"startTime":"0","endTime":"0","summary":"港股上午盘三大指数延续昨日跌势,恒生指数跌0.27%,国企指数跌0.33%,恒生科技指数跌1.1%。大型科网股多数低迷,其中,小米跌2.4%,百度跌1.3%,阿里巴巴、京东、腾讯小幅下跌,美团逆势上涨约2%;内银股、保险股、中资券商股等大金融股多数低迷,进一步令大市承压。另外,铜价新高,铜业股带领有色金属股齐涨,石油股、煤炭股继续活跃。(格隆汇)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260908/32363115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["FTXN","KCAI","03088","XOP","UYM","BNO","SETM","07226","CPER","XLE","COPJ","USE","XES","MHGmain","PXE","GUSH","02837","161032","OIH","PICK","DRIP","IXC","OILT","ICOP","VDE","DRLL","OILK","COPP","DBE","DIG","03033","HGmain","QCmain","03067","159019","PXJ","XME","ERX","IEO","09067","USL","CPXR","OILU","DBC","USOI","COPX","WTIU","DBB","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665344614","title":"兩大板塊,多股漲停!芯片龍頭港股上市首日破發","url":"https://stock-news.laohu8.com/highlight/detail?id=2665344614","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665344614?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 12:27","pubTimestamp":1788841620,"startTime":"0","endTime":"0","summary":"代糖概念板块大涨,多只个股涨停,成为今天(9月8日)上午表现最佳的板块之一。另外,制糖板块也大幅上涨,中粮糖业、*ST广糖均强势涨停。 A股市场今天上午整体窄幅震荡,截至上午收盘,上证 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260908/c679692869.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260908/c679692869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK4585","IPOS","VXUS","BK4588","KCAI","159665"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665765341","title":"港股午評:恒生指數跌0.266%,恒生科技指數跌1.102%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665765341","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665765341?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 12:01","pubTimestamp":1788840062,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VXUS","BK4585","KCAI","BK4588","KTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665341252","title":"港股異動 | 雲頂新耀(01952)早盤升逾5% 星必妥PSVT適應症新藥上市申請在華獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2665341252","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665341252?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 11:53","pubTimestamp":1788839607,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,云顶新耀(01952)早盘涨超5%。截至发稿,涨4.73%,报32.78港元,成交额1.51亿港元。消息面上,9月3日,云顶新耀宣布,国家药品监督管理局(NMPA)已批准星必妥®(艾曲帕米鼻喷雾剂)的新药上市许可申请(NDA),用于治疗成人阵发性室上性心动过速(PSVT)急性症状发作,转复为窦性心律。星必妥已于2025年12月获得美国食品药品监督管理局(FDA)批准,成为30余年来首款且唯一获批用于成人PSVT急性症状发作治疗的创新疗法。此次在中国获批,意味着这一创新疗法正式进入中国市场,成为云顶新耀在心血管疾病领域首个获批产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493208.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","BK1583","BK4585","BK1161","01952","BK1574","IPOS","VXUS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":34,"pageCount":15,"totalSize":669,"code":"91000000","status":"200"}]}}